Sign in
Taking people in United StatesNo phase

Testing a skin hydration sensor in people with sickle cell disease

Checks a skin sensor that measures hydration in people with sickle cell disease.

Key facts

Who runs it
Enrico Novelli
Where
Pittsburgh, United StatesSee the site
Trial code
Registry title
Cutaneous Hydration Assessment in SCD
Status
Recruiting
People taking part
30 people, planned
Started
21 Jan 2022
Expected to end
31 Dec 2027
Type of study
Interventional
Treatments tested
  • Skin Hydration Sensor
Record updated
12 November 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with sickle cell disease who are 12 years old or older. It tests a skin sensor that measures how hydrated the body is.

Age
12 years or older
Sex
All sexes can join.
Disease stage
Sickle cell disease with genotype SS, SC, Sß-thalassemia, SD or SOArab.
Earlier treatment
People being treated with experimental therapies in clinical trials cannot join.

Main reasons for not taking part

  • Under 12 years old
  • Being treated with experimental therapies in clinical trials
  • Not able to give legally effective consent to all study procedures

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Diagnosis of Sickle Cell Disease (genotypes SS, SC, Sß-thalassemia, SD, SOArab)
  • Participants must be ≥12-years old
  • Participants that provide legally effective consent to all study procedures

Who cannot take part

  • Participants being treated with experimental therapies in clinical trials
  • Participants under 12-years old

Where in United States

  • UPMC Sickle Cell ClinicPittsburgh, United StatesContact: Enrico Novelli, MDTaking people

About the trial

What the trial wants to find out

This study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care device for the assessment of hydration status and its potential to guide hydration therapy in patients with sickle cell disease (SCD).

The group in the trial

  • Skin Hydration SensorTreatment being tested

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Cutaneous Hydration Assessment in Sickle Cell Disease
Plain-language title
Testing a skin hydration sensor in people with sickle cell diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
12 November 2025